InnovationWell 2009 Meeting; Philadelphia Oct 09: Program available

1 post / 0 new
Rob Reedijk
Rob Reedijk's picture
InnovationWell 2009 Meeting; Philadelphia Oct 09: Program available

The InnovationWell 2009 community of practice meeting program with abstracts is now complete and available at http://innovationwell.com/comty_conferencesprog09
 
The InnovationWell program will cover discussion of topics on Collaboration in Discovery and Development, Translational Bioinformatics, Systems Biology, Biomarkers, Blood-Brain Barrier Modeling and Predictive Toxicology.
More detailed program below.
 
This annual community of practice meeting is taking place for the fifth time and brings together a unique combination of pharmaceutical and healthcare industry experts, principal investigators and researchers from the academic and government sectors, and leaders from innovative enterprises. The smaller and more intimate meeting format pursued has fostered the type of collaboration not always found at large conferences.
 
Registration fees include food (lunch, dinner, breaks and evening refreshments) for the days attended.  Furthermore, arrangements have been made for some affordable accommodations (preferred rates), making the meeting economical to attend. We now have a great deal of information on preferred rates and travel directions available at http://innovationwell.com/comty_conferencelocation
 

 
Innovation in Life Science & Healthcare R&D
InnovationWell 2009 InterAction Meeting
October 13-16, 2009
Bryn Mawr College, Bryn Mawr, Philadelphia, USA
 
Format: Seminars, Roundtables, Presentations, Panel Q&As, Discussions, Break-out Workshops, Web-supported. Evening Poster sessions, networking, social activities.
 
This meeting will take place concurrently with the eCheminfo 2009 drug discovery community of practice meeting:
http://echeminfo.com/comty_conferencesprog09
 
Call for Abstracts:
If you wish to submit a poster abstract for the meeting which will be placed on the program, please send to Barry Hardy (barry.hardy –(at)- douglasconnect.com) for review. Attractive poster prizes will be awarded for best posters at the meeting (subject to peer review).

A special peer-reviewed issue of Future Medicinal Chemistry with a focus on collaboration in discovery and development is being published from the meeting. Accepted poster and presentation abstracts are eligible for consideration. Please contact Barry Hardy if interested in submitting a paper for review.

 
Pre-Conference Workshop, October 12
Forum on Collaboration in Discovery and Development
To register for the meeting right now, please visit:
http://InnovationWell-BM09.eventsbot.com
To download a pdf of the program including the registration form:
http://barryhardy.blogs.com/files/innovationwell-bm09-90812.pdf
 
 
InnovationWell 2009 Program Summary

MONDAY, OCTOBER 12
Forum on Collaboration in Discovery and Development, Co-chaired by Peter Gates (Johnson & Johnson PR&D) and Barry Hardy (Douglas Connect). Speakers include Barry Hardy (Douglas Connect), Shree Nath (Pointcross), Simson Alex (Johnson & Johnson), Chris Waller (Pfizer), Michael Liebman (Strategic Medicine), Jeff Spitzner (Rescentris), and Bob O’Hara (ResultWorks).
 
 TUESDAY, OCTOBER 13
Translational Bioinformatics: Bridging Bioinformatics and Biomedical Informatics in Translational Medicine, Chaired by Jake Chen (Indiana University). Speakers include Jessica Tenenbaum (Duke Translational Medicine Institute, Duke University), Steve Naylor (Predictive Physiology and Medicine, Inc.), Javed Mostafa (University of North Carolina), Jay Zhang (Myriad Genetics), Maricel Kann (University of Maryland), Iya Khalil (Gene Network Sciences), Hai Hu (Windber Research Institute), Jake Chen (Indiana University – Purdue University), and Susan Stephens (Johnson & Johnson).
 
WEDNESDAY, OCTOBER 14     
Systems Biology and Biomarkers, Chaired by Darius Dziuda (Central Connecticut State University). Speakers include Anamika Sarkar (Novartis), Darius Dziuda (Central Connecticut State University), Frank Tobin (Tobin Consulting LLC), Andreas Matern (Thomson Reuters Healthcare and Science), and Usha Reddy (Merck).
 
Modeling of the Blood–Brain Barrier in Drug Discovery and Development, Chaired by Roméo Cecchelli (Université d'Artois, France). Speakers include Stefan Lundquist (AstraZeneca), Reinhard Gabathuler (AngioChem), Maxime Culot (University of Lille), Damir Janigro (Cleveland Clinic), Marie-Pierre Dehouck (University of Lille), Pierre-Olivier Couraud (Institut Cochin), and Anna Seelig (University of Basel).    
 
THURSDAY, OCTOBER 15
Predictive Toxicology: Combining in vitro and in silico Techniques in Predictive Toxicology Applications, Co-chaired by Richard Judson (US EPA) and Vladimir Poroikov (Institute of Biomedical Chemistry of Russian Academy of Medical Sciences). Speakers include Richard Judson (US EPA), Ellen Berg (BioSeek), Jonathan Dordick (Rensselaer Polytechnic Institute), Barry Hardy (Douglas Connect), Sanji Bhal (ACD/Labs), Christodoulos Floudas (Princeton University), Robert Fraczkiewicz (Simulations Plus), Kyoung Tai No (Yonsei University), and Stephen Bryant (NIH).
 
FRIDAY, OCTOBER 15
Predictive Toxicology: Combining in vitro and in silico Techniques in Predictive Toxicology Applications, Co-chaired by Richard Judson (US EPA) and Vladimir Poroikov (Institute of Biomedical Chemistry of Russian Academy of Medical Sciences). Speakers include Vladimir Poroikov (Institute of Biomedical Chemistry of Russian Academy of Medical Sciences), Fangping Mu (Los Alamos National Laboratory), Katya Tsaioun (Apredica), Grace Patlewicz (DuPont), Michael Pelekis (Simulations Plus), and Anil Aswani (University of California at Berkeley).
 
 
Contact:
Program: Dr. Barry Hardy, InnovationWell Community of Practice, Douglas
Connect. Tel: +41 61 851 0170. email: innovationwell -[at]- douglasconnect.com
Blog: http://barryhardy.blogs.com/

Registration Enquiries: Nicki Douglas, Douglas Connect, Baermeggenweg
14, 4314 Zeiningen, Switzerland. Tel: +41 61 851 0461. innovationwell -[at]- douglasconnect.com
 
Meeting Support: Rob Reedijk, eCheminfo Community of Practice, Douglas
Connect. email: rob.reedijk -[at]- douglasconnect.com